Prognostic Significance of Absolute Lymphocytic Count Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Prognostic Significance of Absolute Lymphocytic Count Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute
Department of Pediatric Oncology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
,
Department of Clinical Pathology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
,
Department of Cancer Epidemiology, National Cancer Institute, Cairo, Egypt
,
Department of Pediatric Oncology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
1 Department of Pediatric Oncology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
2 Department of Clinical Pathology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
3 Department of Cancer Epidemiology, National Cancer Institute, Cairo, Egypt
4 Department of Pediatric Oncology, South Egypt Cancer Institute (SECI), Assiut University, Assiut, Egypt
Background : Leukemia is the most common cause of disease-related death in childhood despite significant improvement in survival and modern risk stratification. Prognostic significance of absolute lymphocytic count (ALC) recovery was studied in pediatric patients with acute lymphoblastic leukemia (ALL). Methods : One hundred twenty one patients newly diagnosed asALL ≤ 18 yearstreated at pediatric oncology department, South Egypt Cancer Institute from 2011 to 2015 were enrolled. Age, sex, initial total leucocytic count, immunophenotyping, central nervous system (CNS) involvement, mediastinal mass, bone marrow (BM) response on day fifteen and after finishing induction remission were compared to ALC recovery on day 15 (ALC-15) and day 29 (ALC-29) of induction response. Also, prognostic impact of ALC recovery on event free survival (EFS) and overall survival (OS) was evaluated. Results : ALC didn’t show any significant relation to known patients’ prognostic factors. Patients with low ALC didn’t show significant lower response on day 15 and post induction evaluation from those with high ALC (p = 0.74, 0.6 respectively). ALC-15 ≥ 500 cells/uL showed a prognostic significance as patients with ALC-15 < 500 cells/uL had a poorer outcome (4- EFS 47.8% ± 0.12 % ) than patients with ALC-15 ≥ 500 cells/uL who carried a better outcome (4-EFS 66.3% ± 0.05 % ). Neither ALC-500 (day 29) nor ALC-350 (day 15 & day 29) had impact on OS or EFS. In multivariate analysis, ALC-15 < 500 cells/uL still had a poor impact on outcome (OR 2.56, 95% CI 1.27 - 5.14) with d15-BM response (OR 2.99, 95% CI 1.35 - 6.61) and age < 10 (OR 1.96, 95% CI 1.01 - 3.69). Conclusions : ALC-15 has an independent prognostic impact on outcome as well as simple, inexpensive, and easy to interpret. Although, it’s utility in risk stratification of ALL still need a confirmation through a multicenter study with uniform variables, large cohort and long duration of follow up.
KeywordsALCPediatric ALLOutcome
Farkas, T., Müller, J., Erdelyi, D.J., Csoka, M. and Kovacs, G.T. (2017) Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia. Pathology & Oncology Research, 23, 889-897. https://doi.org/10.1007/s12253-017-0192-8
Gupta, A., Kapoor, G., Jain, S. and Bajpai, R. (2015) Absolute Lymphocyte Count Recovery Independently Predicts Outcome in Childhood Acute Lymphoblastic Leukemia: Experience from a Tertiary Care Cancer Center of a Developing Country. Journal of Pediatric Hematology/Oncology, 37, e143-e149. https://doi.org/10.1097/MPH.0000000000000249
Basso, G., Veltroni, M., Valsecchi, M.G., Dworzak, M.N., Ratei, R., Silvestri, D., Benetello, A., Buldini, B., Maglia, O., Masera, G., Conter, V., Arico, M., Biondi, A. and Gaipa, G. (2009) Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted by Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow. Journal of Clinical Oncology, 27, 5168-5174. https://doi.org/10.1200/JCO.2008.20.8934
Gaipa, G., Cazzaniga, G., Valsecchi, M.G., Panzer-Grümayer, R., Buldini, B., Silvestri, D., Karawajew, L., Maglia, O., Ratei, R., Benetello, A., Sala, S., Schumich, A., Schrauder, A., Villa, T., Veltroni, M., Ludwig, W.D., Conter, V., Schrappe, M., Biondi, A., Dworzak, M.N. and Basso, G. (2012) Time Point-Dependent Concordance of Flow Cytometry and Real-Time Quantitative Polymerase Chain Reaction for Minimal Residual Disease Detection in Childhood Acute Lymphoblastic Leukemia. Haematologica, 97, 1582-1593. https://doi.org/10.3324/haematol.2011.060426
Stary, J., Zimmermann, M., Campbell, M., Castillo, L., Dibar, E., Donska, S., Gonzalez, A., Izraeli, S., Janic, D., Jazbec, J., Konja, J., Kaiserova, E., Kowalczyk, J., Kovacs, G., Li, C.K., Magyarosy, E., Popa, A., Stark, B., Jabali, Y., Trka, J., Hrusak, O., Riehm, H., Masera, G. and Schrappe, M. (2014) Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002. Journal of Clinical Oncology, 32, 174-184. https://doi.org/10.1200/JCO.2013.48.6522
De Angulo, G., Yuen, C., Palla, S.L., Anderson, P.M. and Zweidler-McKay, P.A. (2008) Absolute Lymphocyte Count Is a Novel Prognostic Indicator in ALL and AML: Implications for Risk Stratification and Future Studies. Cancer, 112, 407-415. https://doi.org/10.1002/cncr.23168
AnocetoMartínez, A., González Otero, A., Guerchicoff de Svarch, E., ArencibiaNunez, A., Jaime, J.C., Dorticos, E., Sarduy, S. and González, L. (2012) Absolute Lymphocyte Count as a Prognostic Factor in Children with Acute Lymphoblastic Leukemia. Anales de Pediatría, 76, 10e1-10e6. https://doi.org/10.1016/j.anpedi.2011.07.001
Sun, D., Elson, P., Liedtke, M., Medeiros, B.C., Earl, M., Alizadeh, A., Bates, J., Sekeres, M.A., Coutre, S., Kalaycio, M., Sobecks, R., Copelan, E. and Advani, A.S. (2012) Absolute Lymphocyte Count on day 28 Independently Predicts Event-Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia. American Journal of Hematology, 87, 957-960. https://doi.org/10.1002/ajh.23279
Rubnitz, J.E., Campbell, P., Zhou, Y., Sandlund, J.T., Jeha, S., Ribeiro, R.C., Inaba, H., Bhojwani, D., Relling, M.V., Howard, S.C., Campana, D. and Pui, C.H. (2013) Prognostic Impact of Absolute Lymphocyte Counts at the End of Remission Induction in Childhood Acute Lymphoblastic Leukemia. Cancer, 119, 2061-2066. https://doi.org/10.1002/cncr.28026
Shen, H.Q., Feng, J.H., Tang, Y.M., Song, H., Yang, S.L., Shi, S.W. and Xu, W.Q. (2013) Absolute Lymphocyte Count Is Associated with Minimal Residual Disease Level in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. Leukemia Research, 37, 671-674. https://doi.org/10.1016/j.leukres.2013.02.002
Hatzipantelis, E., Pana, Z.D., Vlachou, M., Papageorgiou, T., Tragiannidis, A. and Athanassiadou, F. (2014) Peripheral Blood Lymphocyte Recovery and Overall Survival in Pediatric Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer, 61, 181-183. https://doi.org/10.1002/pbc.24736
Cheng, Y., Luo, Z., Yang, S., Jia, M., Zhao, H., Xu, W. and Tang, Y. (2015) The Ratio of Absolute Lymphocyte Count at Interim of Therapy to Absolute Lymphocyte Count at Diagnosis Predicts Survival in Childhood Blineage Acute Lymphoblastic Leukemia. Leukemia Research, 39, 144-150. https://doi.org/10.1016/j.leukres.2014.11.013
Behl, D., Porrata, L.F., Markovic, S.N., Letendre, L., Pruthi, R.K., Hook, C.C., Tefferi, A., Elliot, M.A., Kaufmann, S.H., Mesa, R.A. and Litzow, M.R. (2006) Absolute Lymphocyte Count Recovery after Induction Chemotherapy Predicts Superior Survival in Acute Myelogenous Leukemia. Leukemia, 20, 29-34. https://doi.org/10.1038/sj.leu.2404032
Benjamin, J.E., Gill, S. and Negrin, R.S. (2010) Biology and Clinical Effects of Natural Killer Cells in Allogeneic Transplantation. Current Opinion in Oncology, 22, 130-137. https://doi.org/10.1097/CCO.0b013e328335a559
Norell, H., Moretta, A., Silva-Santos, B. and Moretta, L. (2013) At the Bench: Preclinical Rationale for Exploiting NK Cells and Gamma Delta T Lymphocytes for the Treatment of High-Risk Leukemias. Journal of Leukocyte Biology, 94, 1123-1139. https://doi.org/10.1189/jlb.0613312
Pui, C.H., Campana, D., Pei, D., et al. (2009) Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation. The New England Journal of Medicine, 360, 2730-2741. https://doi.org/10.1056/NEJMoa0900386
Smith, M., Arthur, D., Camitta, B., et al. (1996) Uniform Approach to Risk Classification and Treatment Assignment for Children with Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 14, 18-24. https://doi.org/10.1200/JCO.1996.14.1.18
Rolf, N., Smolen, K.K., Kariminia, A., Velenosi, A., Fidanza, M., Strahlendorf, C., Seif, A.E. and Reid, G.S.D. (2018) Absolute Lymphocyte Counts at End of Induction Correlate with Distinct Immune Cell Compartments in Pediatric B Cell Precursor Acute Lymphoblastic Leukemia. Cancer Immunology, Immunotherapy, 67, 225-236. https://doi.org/10.1007/s00262-017-2070-3
Tosato, F., Bucciol, G., Pantano, G., et al. (2015) Lymphocytes Subsets Reference Values in Childhood. Cytometry Part A, 87, 81-85. https://doi.org/10.1002/cyto.a.22520
Alkayed, K., Halalsheh, H., Khattab, E., et al. (2012). Lack of Prognostic Significance of Absolute Lymphocyte Count after Intensive Induction Therapy in Childhood Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer, 59, 351. https://doi.org/10.1002/pbc.24120